B L Gause
Overview
Explore the profile of B L Gause including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Janik J, Miller L, Korn E, Stevens D, Curti B, Smith 2nd J, et al.
Blood
. 2001 Mar;
97(7):1942-6.
PMID: 11264156
We conducted a phase II randomized trial of recombinant granculocyte-macrophage colony-stimulating factor (GM-CSF) administered before topotecan chemotherapy to determine whether it could prevent myelosuppression and to determine the antitumor activity...
2.
Longo D, Duffey P, Gribben J, Jaffe E, Curti B, Gause B, et al.
Cancer J
. 2000 Jul;
6(3):146-50.
PMID: 10882329
The purpose of this article was to evaluate the antitumor effects of a combination chemotherapy program based on ProMACE (prednisone, methotrexate, doxorubicin [Adriamycin], cyclophosphamide, etoposide) followed by a B cell-specific...
3.
Arun B, Curti B, Longo D, Stevens D, Alvord W, Gause B, et al.
Cancer J Sci Am
. 2000 Mar;
6(1):21-4.
PMID: 10696734
Purpose: Interferon-alfa, 2'-deoxycoformycin, and 2-chlorodeoxy-adenosine (2-CdA) are effective in the management of patients with hairy cell leukemia. These agents produce remissions in most patients, but relapses occur with all three...
4.
Janik J, Miller L, Kopp W, Taub D, Dawson H, Stevens D, et al.
Clin Immunol
. 1999 Dec;
93(3):209-21.
PMID: 10600331
Dendritic cells (DCs) initiate primary and stimulate secondary T-cell responses. We conducted a phase I trial of tumor necrosis factor (TNF-alpha) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with cancer...
5.
Bendandi M, Gocke C, Kobrin C, Benko F, Sternas L, Pennington R, et al.
Nat Med
. 1999 Sep;
5(10):1171-7.
PMID: 10502821
Lymphomas express a tumor-specific antigen which can be targeted by cancer vaccination. We evaluated the ability of a new idiotype protein vaccine formulation to eradicate residual t(14;18)+ lymphoma cells in...
6.
Miller L, Korn E, Stevens D, Janik J, Gause B, Kopp W, et al.
Blood
. 1999 May;
93(10):3250-8.
PMID: 10233876
This dose-escalation study was performed to evaluate the hematologic activity, biological effects, immunogenicity, and toxicity of PIXY321 (an interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein) administered after high-dose carboplatin (CBDCA) treatment. Patients...
7.
Curti B, Ochoa A, Powers G, Kopp W, Alvord W, Janik J, et al.
J Clin Oncol
. 1998 Aug;
16(8):2752-60.
PMID: 9704728
Purpose: We performed a phase I trial to determine whether in vivo expansion of activated CD4+ T cells was possible in cancer patients. 111Indium labeling was used to observe trafficking...
8.
Gause B, Sharfman W, Janik J, Curti B, Steis R, Urba W, et al.
Cancer Invest
. 1998 Jul;
16(6):374-80.
PMID: 9679527
The purpose of this trial was to determine the toxicity and antineoplastic activity of cisplatin, carboplatin, tamoxifen, and interferon-alpha (IFN-alpha) in patients with advanced melanoma. Eleven patients with metastatic melanoma...
9.
Yoe J, Gause B, Curti B, Longo D, Bagg A, Kopp W, et al.
Am J Hematol
. 1998 Mar;
57(3):253-7.
PMID: 9495380
The association of T-cell large granular lymphocyte (LGL) leukemia and rheumatoid arthritis is well described and it is now recognized that these patients and patients with Felty's syndrome represent different...
10.
Janik J, Curti B, Considine R, Rager H, Powers G, Alvord W, et al.
J Clin Endocrinol Metab
. 1997 Sep;
82(9):3084-6.
PMID: 9284748
Leptin, the protein product of the ob gene, regulates appetite and body weight in animals. Endotoxin and cytokines, induced by endotoxin, interleukin (IL) 1 and tumor necrosis factor, increase expression...